Neurobit

About:

Neurobit uses sleep as a biomarker across age, gender and race to predict and prevent adverse health outcomes well before they happen.

Website: https://www.neurobit.com/

Twitter/X: StudyMysleep

Top Investors: Entrepreneur First, Enterprise Singapore, iHealthtech ,NUS

Description:

Neurobit is a leading medical technology company that develops Software as a Medical Device (SaMD) powered by AI to decipher intricate patterns in health vitals measured during sleep, termed 'sleep biomarkers'. This aids in delivering tailored, predictive, and precision healthcare. With a vision to establish a universally accessible health analytics system, Neurobit aims to enhance care quality and efficiency for healthcare professionals and patients. Globally, over 150 esteemed universities, hospitals, and R&D centers rely on our advanced technology solutions.

Total Funding Amount:

2.01M SGD

Headquarters Location:

New York, New York, United States

Founded Date:

2021-06-28

Contact Email:

founders(AT)neurobit.com

Founders:

Amiya Patanaik, Kishan Kishan

Number of Employees:

11-50

Last Funding Date:

2022-02-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai